SLC16A1 and cancer: In this regard, we have evaluated the potential of silicon appended lipophilic CHC analogues 2a-b to inhibit cancer cell proliferation, MCT1 based lactate uptake, disrupt glycolysis and mitochondrial metabolism, and suppress in vivo tumor growth.